136 related articles for article (PubMed ID: 6478396)
1. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.
Kato H; Tamai K; Morioka H; Nagai M; Nagaya T; Torigoe T
Cancer; 1984 Oct; 54(8):1544-6. PubMed ID: 6478396
[TBL] [Abstract][Full Text] [Related]
2. [Prediction of the recurrence of squamous cell carcinoma of the uterine cervix by monitoring serum TA-4].
Oishi T; Maruo T; Yamasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):799-806. PubMed ID: 3598275
[TBL] [Abstract][Full Text] [Related]
3. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
[TBL] [Abstract][Full Text] [Related]
4. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
Kato H; Nagaya T; Torigoe T
Gan; 1984 May; 75(5):433-5. PubMed ID: 6745563
[TBL] [Abstract][Full Text] [Related]
6. Tumor antigen TA-4: an aid in detecting post-operative recurrences of esophageal carcinoma.
Sugimachi K; Kitamura M; Matsuda H; Okudaira Y
Dis Markers; 1987 Jun; 5(2):67-73. PubMed ID: 3502985
[TBL] [Abstract][Full Text] [Related]
7. [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer].
Kato H; Tamai K; Magaya T; Nagai M; Noguchi H; Suehiro Y; Torigoe T
Gan No Rinsho; 1985 May; 31(6 Suppl):594-9. PubMed ID: 4032751
[TBL] [Abstract][Full Text] [Related]
8. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.
Kato H; Morioka H; Tsutsui H; Aramaki S; Torigoe T
Cancer; 1982 Oct; 50(7):1294-6. PubMed ID: 7104971
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
Maruo T; Shibata K; Kimura A; Hoshina M; Mochizuki M
Cancer; 1985 Jul; 56(2):302-8. PubMed ID: 2408732
[TBL] [Abstract][Full Text] [Related]
10. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
[TBL] [Abstract][Full Text] [Related]
11. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Nishino T; Saito J; Abe Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
[TBL] [Abstract][Full Text] [Related]
13. [The clinical usefulness of SCC antigen for diagnosis of recurrent cervical squamous cancer].
Umezawa S; Takeshima N; Shimizu Y; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):165-8. PubMed ID: 7706858
[No Abstract] [Full Text] [Related]
14. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
Geyer H; Schwörer D; Pfleiderer A
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
[TBL] [Abstract][Full Text] [Related]
15. The use of a tumor antigen TA-4 for the management of squamous cell carcinoma.
Kato H; Tamai K; Nagaya T; Nagai M; Torigoe T
Cancer Detect Prev; 1985; 8(1-2):155-9. PubMed ID: 4064035
[TBL] [Abstract][Full Text] [Related]
16. Tumor antigen of human cervical squamous cell carcinoma: correlation of circulating levels with disease progress.
Kato H; Miyauchi F; Morioka H; Fujino T; Torigoe T
Cancer; 1979 Feb; 43(2):585-90. PubMed ID: 421183
[TBL] [Abstract][Full Text] [Related]
17. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
Ievleva ES; Ermoshina NV; Ageenko AI
Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
[TBL] [Abstract][Full Text] [Related]
18. [Squamous cell carcinoma (SCC)--nature and usage in patients with cervical carcinoma].
Bocheva Y; Bochev P; Chaushev B; Ivanov S
Akush Ginekol (Sofiia); 2015; 54(2):29-34. PubMed ID: 25909138
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix.
Kato H; Morioka H; Aramaki S; Tamai K; Torigoe T
Am J Obstet Gynecol; 1983 Feb; 145(3):350-4. PubMed ID: 6824024
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma.
Senekjian EK; Young JM; Weiser PA; Spencer CE; Magic SE; Herbst AL
Am J Obstet Gynecol; 1987 Aug; 157(2):433-9. PubMed ID: 3475982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
